Safety and Effectiveness of Novantrone Therapy Followed by Copaxone

Study Title
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
Teva Identifier
NC-100
ClinicalTrials.gov Identifier
NCT00203073
Study Status
Completed
Trial Condition(s)
Relapsing Remitting Multiple Sclerosis
Interventions
Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 20 mg, with mitoxantrone

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 55 Years
Trial Duration
06/01/2003 - 04/01/2005
Phase
Phase 2

Study Type

Interventional